Hydroxychloroquine in Type 2 Diabetes During Pregnancy

Recruiting now · Not applicable

Conditions studied: Diabetes in Pregnancy, Type 2 Diabetes

In brief

The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment

Key facts

Study ID

NCT06319560

Run by

National University of Malaysia

People needed

56

Starts

2024-03-24

Expected to finish

2027-01-01

Last updated by the study team

2025-06-12

Who can join

Age: 20 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Singleton
• Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus

You may not qualify if…

• autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
• chronic kidney disease
• fetal anomaly
• women on steroid therapy
• diabetic retinopathy
• known thalassaemia or thalassaemia carrier

Where it is running

• Antenatal clinic, UKM Medical Centre — Cheras, Kuala Lumpur, Malaysia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.